Evidence map›Paper›PMID 21979958›Full record

ArticleThe Journal of biological chemistry2011

Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Jessica Finlay-Schultz, Andrew Canastar, Margaret Short, Mohamed El Gazzar, Christina Coughlan, Sherry Leonard

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Galantamine Inhibits AβNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jessica Finlay-SchultzDepartments of Biochemistry and Molecular Genetics, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045; Department of Psychiatry, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045.
Andrew CanastarDepartment of Psychiatry, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045.
Margaret ShortDenver Veterans Affairs Medical Center, Denver, Colorado 80220.
Mohamed El GazzarDepartment of Psychiatry, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045.
Christina CoughlanBiological Sciences Department, University of Denver, Denver, Colorado 80208.
Sherry LeonardDepartment of Psychiatry, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045; Denver Veterans Affairs Medical Center, Denver, Colorado 80220; Department of Pharmacology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado 80045. Electronic address: Sherry.Leonard@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · USDenver VA Medical Center · USUniversity of Denver · US

Funding

Regulation of Alpha 7 Nicotinic Receptor Assembly in Human SmokersR01DA009457 · NIDA · UNIVERSITY OF COLORADO DENVER · PI LEONARD, SHERRY · 1995 to 2011
$2.8M
Regulation of the Human a7 Nicotinic Receptor Gene in SchizophreniaR01MH081177 · NIMH · UNIVERSITY OF COLORADO DENVER · PI LEONARD, SHERRY · 2007 to 2011
$1.7M
NIDA NIH HHS DA009457NIDA NIH HHS R01 DA009457NIMH NIH HHS MH081177NIMH NIH HHS R01 MH081177
6 · The paper itself

Abstract

The CHRNA7 gene, which encodes the α7 nicotinic acetylcholine receptor (α7*nAChR), has been implicated as a candidate gene in schizophrenia. Expression of the α7*nAChR mRNA and protein are reduced in multiple regions of post-mortem brain from patients diagnosed with schizophrenia. Transcriptional regulation may therefore be an important mechanism for the regulation of this gene. A 230-bp proximal promoter fragment, necessary for transcription in cultured neuroblastoma cells, was used to study a putative AP-2α binding site. Mutation of the site indicates that AP-2α plays a negative role in regulating CHRNA7 transcription. This was confirmed through knockdown and overexpression of AP-2α. Electrophoretic mobility shift assays (EMSAs) identified positive DNA-protein interaction at this same site, and supershift assays indicate that the complex includes AP-2α. The interaction was confirmed in cells using chromatin immunoprecipitation (ChIP). DNA methylation was discovered as an anomalous mechanism for CHRNA7 regulation in one cell line. These studies suggest a role for AP-2α regulation of CHRNA7 mRNA expression in multiple tissues during development.

Indexed as

Gene Expression Regulationalpha7 Nicotinic Acetylcholine ReceptorCell Line, TumorDNA MethylationGenetic VectorsHeLa CellsHumansMutagenesis, Site-DirectedMutationPromoter Regions, GeneticReceptors, NicotinicRNA, MessengerRNA, Small InterferingSchizophreniaTranscription Factor AP-2Transcription, Geneticalpha7 Nicotinic Acetylcholine ReceptorChrna7 protein, humanReceptors, NicotinicRNA, MessengerRNA, Small InterferingTranscription Factor AP-2

Identifiers

PMID21979958
PMCPMC3234925
OpenAlexW2120022620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.